Cargando…

COVID-19 infection: mitohormetic concept of immune response

Detalles Bibliográficos
Autores principales:	Gebicki, Jerzy, Wieczorkowska, Marzena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359918/ https://www.ncbi.nlm.nih.gov/pubmed/32690996 http://dx.doi.org/10.1038/s41420-020-00297-9

Ejemplares similares

The mitohormetic response as part of the cytoprotection mechanism of berberine: Berberine induces mitohormesis and mechanisms
por: Zhu, Xiaofei, et al.
Publicado: (2020)

COVID-19 cytokine storm syndrome: a threshold concept
por: Chen, Luke Y C, et al.
Publicado: (2021)

Harmonizing Magnetic Mitohormetic Regenerative Strategies: Developmental Implications of a Calcium–Mitochondrial Axis Invoked by Magnetic Field Exposure
por: Franco-Obregón, Alfredo
Publicado: (2023)

The antibody response of haematological malignancies to COVID-19 infection and vaccination
por: Seebacher, Nicole A.
Publicado: (2022)

Controlled obesity status: a rarely used concept, but with particular importance in the COVID-19 pandemic and beyond
por: Halpern, B., et al.
Publicado: (2020)

COVID-19 herd immunity: where are we?
por: Fontanet, Arnaud, et al.
Publicado: (2020)

The elusive goal of COVID-19 vaccine immunity
por: Abu-Raddad, Laith J, et al.
Publicado: (2023)

Hybrid immunity and strategies for COVID-19 vaccination
por: Hui, David S
Publicado: (2023)

Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry
por: Seror, Raphaèle, et al.
Publicado: (2022)

COVID-19 herd immunity by immunisation: are children in the herd?
por: Obaro, Stephen
Publicado: (2021)

Can the microcirculatory response to hypoxia be a prognostic factor for Covid-19?
por: Gebicki, Jerzy, et al.
Publicado: (2020)

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab
por: Smetanova, Jitka, et al.
Publicado: (2022)

COVID-19 vaccine design: the Janus face of immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

COVID-19 vaccines: modes of immune activation and future challenges
por: Teijaro, John R., et al.
Publicado: (2021)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Considerations of hybrid immunity and the future of adolescent COVID-19 vaccination
por: Irving, Stephanie A, et al.
Publicado: (2023)

Management of pregnant women infected with COVID-19
por: Luo, Yongwen, et al.
Publicado: (2020)

Blood lipids after COVID-19 infection
por: Durrington, Paul
Publicado: (2023)

COVID-19 infection, reinfection, and the transition to endemicity
por: Cohen, Cheryl, et al.
Publicado: (2023)

Assessing national performance in response to COVID-19
por: Fisher, Dale, et al.
Publicado: (2020)

Refugee and migrant health in the COVID-19 response
por: Kluge, Hans Henri P, et al.
Publicado: (2020)

Trained innate immunity, COVID-19 therapeutic dilemma, and fake science
por: Belizário, José Ernesto
Publicado: (2020)

Covid-19 and its impact on immunization programs: reflections from Brazil
por: Matos, Camila Carvalho de Souza Amorim, et al.
Publicado: (2020)

After 62 years of regulating immunity, dexamethasone meets COVID-19
por: Cain, Derek W., et al.
Publicado: (2020)

Not just antibodies: B cells and T cells mediate immunity to COVID-19
por: Cox, Rebecca J., et al.
Publicado: (2020)

Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?
por: Zhang, Shen-Ying, et al.
Publicado: (2020)

What are the risks of COVID-19 infection in pregnant women?
por: Qiao, Jie
Publicado: (2020)

Antimicrobial use, drug-resistant infections and COVID-19
por: Rawson, Timothy M., et al.
Publicado: (2020)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

Understanding of COVID-19 from infection–fatality ratio
por: Gu, Xiaoying, et al.
Publicado: (2022)

Decisive leadership is a necessity in the COVID-19 response
por: Al Saidi, Ahmed Mohammed Obaid, et al.
Publicado: (2020)

Hard to reach: COVID-19 responses and the complexities of homelessness
por: Flook, Mary, et al.
Publicado: (2020)

Sex workers must not be forgotten in the COVID-19 response
por: Platt, Lucy, et al.
Publicado: (2020)

Dysregulation of type I interferon responses in COVID-19
por: Acharya, Dhiraj, et al.
Publicado: (2020)

The potential danger of suboptimal antibody responses in COVID-19
por: Iwasaki, Akiko, et al.
Publicado: (2020)

Crowdsourcing a crisis response for COVID-19 in oncology
por: Desai, Aakash, et al.
Publicado: (2020)

The right to health must guide responses to COVID-19
por: Pūras, Dainius, et al.
Publicado: (2020)

The World Bank COVID-19 response: Politics as usual?
por: Kilby, Christopher, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ttnnlqbi72gp7snboomlhnuk8j